Replacement of Renal Function by Dialysis

ISBN-13: 9789401741781 / Angielski / Miękka / 2014 / 1536 str.

C. Jacobs; Carl Kjellstrand; Karl-Martin Koch

Opis

In this chapter, the term 'renal osteodystrophy' will be used in a generic sense to include all the clinical syn- dromes of skeletal disease and altered calcium (Ca) and phosphorus (P) homeostasis resulting from chronic renal failure (CRF). The skeletal pathology can include osteitis TAHQgT 0BQAN8 fibrosa and other features of secondary hyperparathy- OUT roidism, osteomalacia, aplastic or adynamic bone disease, PARATHVnOO QLAND osteoporosis, osteosclerosis, and in children, retardation of growth. Emphasis will be placed on the manifestations Figure I. Schema showing the conversion of vitamin D3 (D3) of these syndromes that occur in patients on maintenance to 25-hydroxyvitamin D3 (25(OH)D3 or calciferol) in the liver dialysis with a consideration of pathogenesis, prevention and subsequently to 1,25 dihydroxyvitamin Dj (l,25[OH)2D3 and management. or calcitriol) in the kidney. Vitamin D through a specific action on collagen metabolisnh. There The term, vitamin D, is used to include vitamin D, or are also cellular receptors for calcitriol in the parathyroid cholecalciferol, the naturally occurring sterol present in glands, pancreas, kidneys, and salivary glands, although animals, and vitamin D, or ergocalciferol, a sterol gener- its action in these tissues are uncertain. Recently, calcitriol ated through the ultraviolet irradiation of plant precursors.

Recenzje

... about previous editions ...
`The standard reference book for the artificial kidney world.'
JAMA
`The aim of the authors - to produce a standard text for nephrologists and those with an interest in today's treatment of renal failure - is fully achieved.'
Urological Research
`A superb book ... the detail and depth of discussions are unequalled in any current nephrology text.'
Mayo Clinic Proceedings

Spis treści

Foreword; B.H. Scribner. Tribute to the founding editors. List of contributors. List of illustrations. I: Pathophysiology of the uremic syndrome. Principles and biophysics of dialysis. 1. Uremic syndrome; R. Vanholder, et al. 2. Principles and biophysics of dialysis; J.A. Sargent, F.A. Gotch. 3. Membranes for dialysis; C. Colton, M.J. Lysaght. 4. Biophysics of UF and HF; L.W. Henderson. 5. Peritoneal anatomy and physiology during PD; R.T. Krediet. 6. Biocompatibility - principles; R.M. Hakim, J. Himmelfarb. II: Technology of dialysis and associated methods. 7. Hemodialysers and associated devices; N.A. Hoenich, et al. 8. Water preparation; B.J. Canaud, C.M. Mion. 9. Hemodialysis fluid composition; C. Ronco, et al. 10. Hemodialysis access: A: Temporary; P.R. Uldall. B: Permanent; C.E. Butler, N. Tilney. 11. Malfunctioning hemodialysis access: diagnosis and percutaneous treatment; D. Vorwerk, et al. 12. Thrombogenesis and anticoagulation in patients undergoing chronic hemodialysis; G. Vigano, et al. 13. HD machines and monitors; H.D. Polaschegg, N.W. Levin. 14. UF and HF practices; E. Quellhorst. 15. Continuous arteriovenous hemofiltration and related therapies; A.A. Kaplan. 16. Pros and cons of short high efficiency and high flux dialysis; R. Barth. 17. Dialyser reuse-techniques and controversy; A.M. Miles, E.A. Friedman. 18. Extracorporeal blood purification techniques: plasmapheris and hemoperfusion; J.F. Winchester, et al. 19. Peritoneal dialysis access, placement, connectors; B. Piraino. 20. Solutions for PD; M. Feriani, et al. 21. Automated PD; J. Diaz-Buxo. 22. Continuous PD; C.M. Mion. III: Quantification and prescription of dialysis. 23. Indications for long term results and limitations of PD; D.N. Churchill. 24. Quantification and prescription. General principles; P. Blake, J. Daugirdas. IV: Complications of dialysis. 25. Peritoneal infections, hernias and related complications; R. Gokal. 26. Acute complications of hemodialysis and their prevention and treatment; S.K. Mujais, et al. 27. Pyrogenic reactions; G. Lonneman, K.M. Koch. 28. Biocompatibility &endash; Clinical aspects; H. Lemke, et al. V: Pharmacological considerations. 29. Drug dosage in dialysis patients; Th.A. Golper, et al. VI: Special clinical situations. 30. Acute renal failure; C.M. Kjellstrand, B.P. Teehan. 31. Renal replacement therapy in children; R. Donckerwolcke, et al. 32. Dialysis in the elderly; E. Grapsa, D.G. Oreopoulos. 33. Pregnancies in women on renal replacement therapy; A.J. Wing, J.H.H. Ehrich. 34. The dialysis patient and transplantation; U. Frei. 35. Dialytic management of diabetic uremic patients; E. Friedman, A.V. Miles. 36. Anesthesia; B.L. Kasiske. VII: Organ system and metabolic complications in chronic dialysis. 37. Blood